Medivolve Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was CAD 25.27 million. Net income was CAD 6.86 million compared to net loss of CAD 2.3 million a year ago. Basic earnings per share from continuing operations was CAD 0.02 compared to basic loss per share from continuing operations of CAD 0.03 a year ago. For the nine months, sales was CAD 40.26 million. Net loss was CAD 12.01 million compared to CAD 10.58 million a year ago. Basic loss per share from continuing operations was CAD 0.05.